Interleukin-1 receptors and receptor antagonist in haemodialysis
Author(s) -
D Donati,
Dimitrios Degiannis,
Emanuele Mazzola,
L Gastaldi,
Jana Rašková,
K Raska,
Giovanni Camussi
Publication year - 1997
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/12.1.111
Subject(s) - medicine , receptor , receptor antagonist , interleukin 1 receptor antagonist , hemodialysis , peripheral blood mononuclear cell , endocrinology , end stage renal disease , population , antagonist , interleukin , immunology , cytokine , biology , in vitro , biochemistry , environmental health
Biological activity of interleukin-1 (IL-1) depends on the number and type of IL-1 receptors on target cells and on the amounts of its naturally occurring inhibitor, the IL-1 receptor antagonist (IL-1ra).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom